Blumhouse just crossed an impressive 2024 box office milestone thanks to the continued box office success of Speak no evil. Served as an English-language remake of the 2022 Danish film of the same name by director Christian Tafdrup, James Watkin’s Speak no evil Follows a family as they go to spend the weekend at another family’s countryside home, soon discovering that something sinister is happening. The film, which stars James McAvoy, Mackenzie Davis, Scoot McNairy, Aisling Franciosi, hit theaters in mid-September to mostly positive reviews.
A new report from Collider Now reveals that Speak no evil Earned $43 million worldwide, comprising $22 million domestic and $21 million from overseas territories. This total not only makes the film, which was budgeted at $15 million, a success, but it means Blumhouse, led by CEO Jason Blum, has now crossed $150 million in growth worldwide by 2024. While not all of the company’s 2024 films have been hits on their own, they’ve certainly combined to make it a stellar year for the company.
What the success of speaking no evil means for Blumhouse
How the film compares to 2024’s other Blumhouse horrors
Speak no evil Reviews are generally positive from critics, and the film, as a result, has an 83% on Rotten tomatoesWith the audience score comes in even higher at 85%. While not all of Blumhouse’s 2024 movies were as warmly received as this one, most were financial successes.
The company started the year off with Night swimWhich earned $54 million on a $15 million budget, despite mostly negative reviews. imagined It was another critical flop, but it grossed $43 million on a $13 million budget. The release of Afraid August is Blumhouse’s only major flop of the year so far, with that film topping out at $11.5 million against a $12 million budget.
Related
Blumhouse continues to excel because it works almost exclusively in the horror genre and with lower budgets. Unlike a $150 million blockbuster, A Blumhouse horror like Speak no evil Just really needs to get between $30-$37 million to reach profitability. With the audience for horror being quite reliable in terms of theater turnout year-after-year, consistently hitting these types of numbers is much more possible. The company obviously has a formula that works and will likely continue to pay dividends.
Our take on Blumhouse’s successful 2024
The company has found a great strategy
While not all Blumhouse movies are good, The company has certainly shown that building a slate of four out of five smaller movies can be just as effective, if not more so, than building one based on one giant blockbuster.. The company always has a release on the horizon, meaning there is always a horror or thriller movie that the audience can look forward to.
Speak no evil is one of the better Blumhouse movies in recent years, and it would be refreshing if the theatrical landscape received more movies budgeted around $15 million with recognizable stars and strong scripts. It remains to be seen whether 2025 will bring the same level of success for Blumhouse, but the company’s consistency so far would suggest it’s still a strong year ahead.
Source: Collider